Information  X 
Enter a valid email address

Medica Group PLC (MGP)

  Print   

Thursday 12 November, 2020

Medica Group PLC

Director/PDMR Shareholding

RNS Number : 0342F
Medica Group PLC
12 November 2020
 

 

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 10 November 2020, the PDMR listed below was granted options over ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017 at a nil exercise price:

Name of PDMR

Number of shares subject to option

Richard Jones

443,077

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Mr Richard Jones

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification in each case

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Medica Group PLC

b)

 

LEI

 

213800B8XE5FUSZF5Z16

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")



b)

 

Nature of the transaction

 

 

Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017

c)

 

Price(s) and volume(s)

Exercise Price nil




d)

 

Aggregated information

N/A

e)

 

Date of the transaction

 

 

10 November 2020

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKDBNABDDPDD

a d v e r t i s e m e n t